ResearcherBursa Uludağ Üni̇versi̇tesi̇No recent work listed
Murat Yalçın
Matched on ORCID iD 0000-0002-5600-8162; OpenAlex author ID A5059546960. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 3
- Editorial Expression of Concern: Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles. Co-author DOI 10.1007/s12672-023-00668-5↗
- Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin. First author DOI 10.1016/j.canlet.2014.04.016↗
- Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles. Co-author DOI 10.1007/s12672-013-0137-y↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Thangirala Sudha · 3 shared papers, 2013–2023 · strength 0.26
- Paper Editorial Expression of Concern: Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanop… DOI 10.1007/s12672-023-00668-5↗
- Paper Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin. DOI 10.1016/j.canlet.2014.04.016↗
- Paper Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles. DOI 10.1007/s12672-013-0137-y↗
- Shaker A. Mousa · 3 shared papers, 2013–2023 · strength 0.26
- Paper Editorial Expression of Concern: Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanop… DOI 10.1007/s12672-023-00668-5↗
- Paper Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin. DOI 10.1016/j.canlet.2014.04.016↗
- Paper Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles. DOI 10.1007/s12672-013-0137-y↗
- Thiruvengadam Arumugam · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.